These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3710265)
21. Adjuvant treatment of ovarian carcinoma with tranexamic acid. Astedt B J Clin Pathol Suppl (R Coll Pathol); 1980; 14():74-6. PubMed ID: 6933159 [No Abstract] [Full Text] [Related]
22. Influence of tranexamic acid and acetylsalicylic acid on the thickness of the normal cornea. Olsen T; Ehlers N; Bramsen T Acta Ophthalmol (Copenh); 1980 Oct; 58(5):767-72. PubMed ID: 7211265 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of tumour vascularization by tranexamic acid. Experimental studies on possible mechanisms. Sundbeck A; Karlsson L; Lilja J; Peterson HI Anticancer Res; 1981; 1(5):299-304. PubMed ID: 6179454 [TBL] [Abstract][Full Text] [Related]
24. [Experimental studies of tranexamic acid (AMCHA)]. Marmo E; Imperatore A; Chieppa S; Brita G; Spadaro R; Cecchetti M Arch Sci Med (Torino); 1975; 132(1):9-23. PubMed ID: 1171672 [No Abstract] [Full Text] [Related]
25. On the effects of tranexamic acid and its isobenzedrine ester on plasminogen activation and streptokinase induced fibrinolysis. Baldacci M; Catalani R; Bartoli C; Del Corso A; Tozzi MG; Mura U Boll Soc Ital Biol Sper; 1989 Jun; 65(6):521-8. PubMed ID: 2611013 [TBL] [Abstract][Full Text] [Related]
26. Effects of tranexamic acid on fibrinolysis, fibrinogenolysis and amidolysis. Takada A; Makino Y; Takada Y Thromb Res; 1986 Apr; 42(1):39-47. PubMed ID: 3705023 [TBL] [Abstract][Full Text] [Related]
27. Characterization of newly established cell line HUOA from a human ovarian serous cystadenocarcinoma. Ishiwata I; Ishiwata C; Kobayashi N; Ishikawa H Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):831-6. PubMed ID: 3598277 [TBL] [Abstract][Full Text] [Related]
28. Establishment and characterisation of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies. Hill BT; Whelan RD; Gibby EM; Sheer D; Hosking LK; Shellard SA; Rupniak HT Int J Cancer; 1987 Feb; 39(2):219-25. PubMed ID: 3804493 [TBL] [Abstract][Full Text] [Related]
29. A double-blind study of the influence of tranexamic acid on the central corneal thickness after cataract extraction. Bramsen T; Corydon L; Ehlers N Acta Ophthalmol (Copenh); 1978 Feb; 56(1):121-6. PubMed ID: 345733 [TBL] [Abstract][Full Text] [Related]
30. [Establishment of a cell line from human ovarian cancer (undifferentiated carcinoma of FIGO classification) and analysis of its cell-biological characteristics and sensitivity to anticancer drugs]. Yoshiya N Nihon Sanka Fujinka Gakkai Zasshi; 1986 Oct; 38(10):1747-53. PubMed ID: 3782955 [TBL] [Abstract][Full Text] [Related]
31. Failure of tranexamic acid to influence the ellagic acid-induced hypercoagulable state. Girolami A; Cella G; Burul A; Zucchetto M Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):261-70. PubMed ID: 61921 [TBL] [Abstract][Full Text] [Related]
32. Effects of tranexamic acid on the conversion of Glu-plasminogen I and II to its Lys-forms. Takada A; Takada Y Thromb Res; 1985 Oct; 40(2):171-9. PubMed ID: 2933845 [TBL] [Abstract][Full Text] [Related]
33. Effects of tranexamic acid and urokinase on hematogenous metastases of Lewis lung carcinoma in mice. Tanaka N; Ogawa H; Tanaka K; Kinjo M; Kohga S Invasion Metastasis; 1981; 1(3):149-57. PubMed ID: 7188385 [TBL] [Abstract][Full Text] [Related]
34. [Colony growth by various malignant cells of cancer patients on in vitro colony assay]. Inoue K; Arakawa M; Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ikeda K; Usui N; Nakada H; Adachi K Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1456-63. PubMed ID: 6520505 [No Abstract] [Full Text] [Related]
36. Degradation of Glu- and Lys-plasminogen by elastase in the presence or absence of tranexamic acid. Takada A; Sugawara Y; Takada Y Thromb Res; 1988 Apr; 50(2):285-94. PubMed ID: 3394116 [TBL] [Abstract][Full Text] [Related]
37. Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo. Ning S; Shui C; Khan WB; Benson W; Lacey DL; Knox SJ Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):177-87. PubMed ID: 9422575 [TBL] [Abstract][Full Text] [Related]
38. Enhancement of the activation of Glu-plasminogen by urokinase in the simultaneous presence of tranexamic acid or fibrin. Takada A; Sugawara Y; Takada Y Haemostasis; 1989; 19(1):26-31. PubMed ID: 2920977 [TBL] [Abstract][Full Text] [Related]
39. Clear cell carcinoma of the ovary with colony-stimulating-factor production. Occurrence of marked granulocytosis in a patient and nude mice. Takeda A; Suzumori K; Sugimoto Y; Yagami Y; Miyazawa T; Yamada C; Matsuyama M Cancer; 1984 Sep; 54(6):1019-23. PubMed ID: 6331875 [TBL] [Abstract][Full Text] [Related]
40. A newly established cel line derived from human ovarian adenocarcinoma. Sekiguchi M; Sakakibara K; Suzuki T; Motoyama T; Fujii G Jpn J Exp Med; 1980 Aug; 50(4):283-92. PubMed ID: 7441907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]